CIK 0001034842
- Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943248524
- Phone
- +1 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-11-18 | Masuda Esteban Sr. VP Research | Sale · Employee Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2019-03-20 | Masuda Esteban Sr. VP Research | Grant or award · Employee Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2019-01-23 | Masuda Esteban Sr. VP Research | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2018-05-09 | Masuda Esteban Sr. VP Research | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-01-24 | Masuda Esteban Sr. VP Research | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2017-02-02 | Masuda Esteban Sr. VP Research | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 |
Page 1 of 1 · 6 trades